Mouse Models of Diet-Induced Nonalcoholic Steatohepatitis Reproduce the Heterogeneity of the Human Disease
Mariana Verdelho Machado(Champalimaud Foundation), Anna Mae Diehl(Duke Medical Center)
Cited by 381
Related Papers
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
|The Lancet|2014|2.2k
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
|Hepatology|2007|1k
Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis
|Hepatology|2013|374
Dysregulated metabolism contributes to oncogenesis
|Seminars in Cancer Biology|2015|318